Skip to main content
. 2016 Jul 30;7(35):57036–57049. doi: 10.18632/oncotarget.10958

Figure 4. Flow chart describing the patient cohorts analyzed in this study.

Figure 4

A total of 219 patients with BCR-ABL1 rearrangement-negative MPNs were enrolled. Because coexisting JAK2 and CALR mutations were observed in the ET patients in the first patient cohort (n = 123), a second cohort of 96 ET patients was added. According to the mutational status of JAK2 or CALR and the type of CALR mutation, the clinical and laboratory characteristics were analyzed in the 167 ET patients. Abbreviations: ET, essential thrombocythemia; PMF, primary myelofibrosis; PV, polycythemia vera; CNL, chronic neutrophilic leukemia; WBC, white blood cell, Hb, hemoglobin; LDH, lactate dehydrogenase.